CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.
The CRI Irvington Postdoctoral Fellowship Program supports early-career scientists in immunology and cancer immunology research, fostering innovation and leadership through funding and mentorship from the Cancer Research Institute.
CRI Technology Impact Award supports technology developers and clinical cancer immunologists in creating unbuilt, untested technologies to overcome barriers and enable more effective cancer immunotherapies.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
CRI IGNITE Award supports postdoctoral researchers with mentored and early-faculty research funding to establish independent cancer immunology programs and advance the development of cancer immunotherapies.